Abstract
Objective: To evaluate whether the dermal exposure to N,N-dimethylformamide (DMF) exerts significant effects and to determine the unit increment of dermal exposure on the total body burden of two biomarkers in urine: metabolism-required N-methylformamide (U-NMF) and non-metabolized DMF (U-DMF) in actual occupational environments. Methods: Exposure via respiratory and dermal routes was assessed on an individual basis for 75 workers from four DMF-related factories directly exposed to DMF. Respiratory exposure was determined by breathing-zone sampling for a full-work shift, and dermal exposure was assessed on the palms and forearms of both hands by an adhesive tape-patch method. U-NMF and U-DMF collected immediately postshift were measured. Results: The average concentrations of airborne DMF, DMF on hands and on forearms, U-NMF, and U-DMF (GM) were 1.51 ppm, 0.04 μg/cm2, 0.03 μg/cm2, 0.47 mg/l, and 0.38 mg/l, respectively. In multiple linear regression tests, only airborne DMF and DMF on hands remained significantly (P<0.001) associated with U-NMF and U-DMF. Based on model estimates, the unit increment of hands' exposure (μg/cm2) could contribute to 0.53 and 0.46 mg/l of the increment of U-NMF and U-DMF, respectively, given a daily occupational airborne exposure to DMF at about 1.5 ppm. Conclusions: Dermal exposure provides a substantial contribution to the total body burden of DMF. A control remedy such as the enforcement of wearing impermeable gloves by workers occupationally exposed to DMF should be implemented with the highest priority.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Conference of Governmental Industrial Hygienists (ACGIH). Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. ACGIH, Cincinnati, OH, USA, 1999.
Brindley C., Gescher A., and Ross D. Studies of the metabolism of dimethylformamide in mice. Chem Biol Interact 1993: 45: 387–392.
Calvert G.M., Fajen J.M., Hills BW, and Halperin WE Testicular cancer dimethylformamide leather tanneries. Lancet 1990: 336(8725): 1253–1254.
Chang H.Y., Shih T.S., Cheng C.C., Tsai C.Y., Lai J.S., and Wang V.S. The effects of co-exposure to methyl ethyl ketone (MEK) on the biological monitoring of occupational exposure to N, N-dimethylformamide (DMF). Int Arch Environ Occup Health 2003: 76: 121–128.
Deutsche Forschungsgemeinschaft. Maximale Arbeitsplatzkonezentrationen und biologische Arbeitsstofftoleranzwerte. Mitteilung 33, Senatskommission zur Prufunggesundheitsschadlicher Arbeitsstoffe Wiley-VCH, Weinheim, Germany, 2000.
Gescher A. Metabolism of N,N-dimethylformamide: key to the understanding of its toxicity. Chem Res Toxicol 1993: 6: 245–251.
Hansen E., and Meyer O. Embryotoxicity and teratogenicity study in rats dosed epicutaneously with dimethylformamide (DMF). J Appl Toxicol 1990: 10(5): 333–338.
Henry R.J., Cannon D.C., and Winkleman J.W. Automated determination of serum and urine creatinine. Henry, R.J., Cannon D.C, and Winkleman J.W. In: (Eds.) Clinical Chemistry, Principles and Technique. Harper & Row. New York, 1974, pp. 552–555.
Hornung R.W. and Reed L.D. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990: 5(1): 46–51.
Kafferlein H.U., Goen T., Muller J., Wrbitzky R., and Angerer J. Biological monitoring of workers exposed to N,N-dimethylformamide in the synthetic fibre industry. Int Arch Occup Environ Health 2000: 73(2): 113–120.
Kafferlein H.U., and Angerer J. Simultaneous determination of two human urinary metabolites of N,N-dimethylformamide using gas chromatography—thermionic sensitive detection with mass spectrometric confirmation. J Chromatogr B 1999: 734: 285–298.
Kestell P., Gill M.H., Threadgill M.D., Gescher A., Hnwarth O.W., and Curzon E.H. Identification by proton NMR of N-(hydroxymethyl)-N-methylformamide as the major urinary metabolite of N,N-dimethylformamide in mice. Life Sci 1986: 38: 719–724.
Kuo H.W., Huang Y.S., Lo J.C., Cheng T.J., and Chang M.J. Exposure to solvents in a synthetic leather manufacturing plant. Int Arch Occup Environ Health 2000: 73(4): 275–280.
Lareo A.C., and Perbellini L. Biological monitoring of workers exposed to N,N-dimethylformamide. II. Dimethylformamide and its metabolites in urine of exposed workers. Int Arch Occup Environ Health 1995: 67: 47–52.
Mráz J., Jheeta P., Gescher A., Hyland R., Thummel K., and Threadgill M.D. Metabolism of N,N-dimethylformamide: key to the understanding of its toxicity. Chem Res Toxicol 1993: 6: 245–251.
Mraz J., and Nohova H. Percutaneous absorption of N,N-dimethylformamide in humans. Int Arch Occup Environ Health 1992: 64(2): 79–83.
Nomiyama T., Nakashima H., Chen L.L., Tanaka S., Miyauchi H., and Yamauchi T. N,N-dimethylformamide: significance of dermal absorption and adjustment method for urinary N-methylformamide concentration as a biological exposure item. Int Arch Occup Environ Health 2001: 74(3): 224–228.
Rosenberg J., Fiserova-Bergerova V., and Lowry L.K. Measurements in urine. In: Biological Exposure Indices Committee (Eds.) Topics in Biological Monitoring. American Conference of Governmental Industrial Hygienists (ACGIH) Cincinnati. OH, USA, 1995, pp. 25–32.
Rougier A., Dupuis D., Lotte C., and Maibach H.I. Stripping method for measuring percutaneous absorption in vivo. In: Brnaugh R.L., Maibach H.I. (Eds.) Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology. 3rd edn New York, Marcel Dekker, Inc, 1999, pp. 375–394.
Scailteur V., DeHoffmann E., Buchet J.P., and Lauwerys R. Study on in vivo and in vitro metabolism of dimethylformamide in male and female rats. Toxicology 1984: 29: 221–234.
Schneider T., Cherrie J.W., Vermeulen R., and Kromhout H. Dermal exposure assessment. Ann Occup Hyg 2000: 44: 493–499.
Wrbitzky R., and Angerer J. N,N-dimethylformamide--influence of working conditions and skin penetration on the internal exposure of workers in synthetic textile production. Int Arch Occup Environ Health 1998: 71(5): 309–316.
World Health Organization (WHO) Regional Office for Europe. Guiding principles for the use of biological markers in the assessment of human exposure to environmental factors: an integrative approach of epidemiology and toxicology. Toxicology 1995: 101: 1–10.
Yang J.S., Kim E.A., Lee M.Y., Park I.J., and Kang S.K. Biological monitoring of occupational exposure to N,N-demethylformamide the effects of co-exposure to toluene or dermal exposure. Int Arch Occup Environ Health 2000: 73: 463–470.
Acknowledgements
This study was partially funded by a grant (Project No. IOSH91-A315) from the Institute of Occupational Safety and Health, Council of Labor Affairs, Taiwan. We thank the study participants and their employers for their co-operation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chang, HY., Tsai, CY., Lin, YQ. et al. Urinary biomarkers of occupational N,N-dimethylformamide (DMF) exposure attributed to the dermal exposure. J Expo Sci Environ Epidemiol 14, 214–221 (2004). https://doi.org/10.1038/sj.jea.7500316
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jea.7500316